10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Tri-City Cardiology’s Ambulatory Surgical Center Surpasses 6,000 Procedures, Marking a Major Milestone in Outpatient Cardiovascular Care
LG NOVA UNVEILS NEXT GENERATION OF AI-FIRST VENTURES AT CES 2026
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2026 Calls for a Global Health System Connectivity Compact: EHR/EMR, Interoperability, and Cybersecurity Vendors Urged to Protect Continuity of Care During Conflict and Recovery
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on...
SAN DIEGO, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing...
Consolidated Net Revenue of $12.2 Million Down 2% vs. Third Quarter of 2020 and Up 14% vs. Second Quarter of 2021U.S....
-Product is the first generic alternative to one of the highest priced pharmaceutical products in the worldDEER PARK, Ill., Oct....
CHARLOTTESVILLE, Va., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company...
Reports record revenue of $178.2 million for the quarter, representing year-over-year growth of 89% and organic growth of 77%Raises revenue...
ALPHARETTA, Ga., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to...
ANN ARBOR, Mich., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the...
Press Release 28 October 2021 Immunicum to Host Investor Meeting with CEO Immunicum AB (publ; IMMU.ST) today announced that on...
Novadip Biosciences announces EUR 19 million Series B financing backed by international investors New investment to fuel continued growth of...
GEN-011 neoantigen-targeted peripheral T cell therapy clinical trial continues Strong presence at the SITC 36th Annual Meeting Conference call today...
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives...
-Financing Will Pave Way for Expansion of Product Portfolio and Global Footprint & Provides Sufficient Resources to Deliver on Key...
Company celebrates three consecutive years of leading e-prescription accuracy for Tier 1 EHRs, adds RxChange Champion award to its accolades...
Early detection of viral infections may be as easy as wearing a smartwatch physIQ app embedded in watch collects physiological...
Company Placing Renewed Emphasis on the Country’s ‘Stroke Belt’, Increasing its Commitment to Address the Growing Needs of Stroke Patients...
Third-quarter revenue of $3.2 billion increased 9% on a reported basis, 7% on a constant currency basis and 6% on...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to...
Substantial financial commitment will kick-start multi-billion-dollar external investment to address entrenched healthcare challenges Platform to combine clinicians, scientists, venture capital...
The acquisition of BEPATIENT puts Alira Health firmly on the path of merging biopharma, medical, and digital technology development with...
